Name | Number of supported studies | Average coverage | |
---|---|---|---|
ciliated cell | 14 studies | 33% ± 11% | |
astrocyte | 4 studies | 30% ± 9% | |
glutamatergic neuron | 3 studies | 18% ± 2% | |
ependymal cell | 3 studies | 50% ± 9% |
Insufficient scRNA-seq data for expression of EFHC2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 97% | 215.59 | 175 / 180 | 90% | 4.82 | 388 / 430 |
prostate | 99% | 284.23 | 243 / 245 | 77% | 2.05 | 389 / 502 |
kidney | 88% | 142.11 | 78 / 89 | 76% | 4.99 | 689 / 901 |
thymus | 100% | 304.96 | 650 / 653 | 61% | 2.18 | 369 / 605 |
brain | 86% | 192.43 | 2285 / 2642 | 71% | 4.20 | 499 / 705 |
esophagus | 96% | 185.87 | 1384 / 1445 | 59% | 1.72 | 108 / 183 |
uterus | 100% | 401.06 | 170 / 170 | 49% | 2.76 | 225 / 459 |
lung | 79% | 205.25 | 456 / 578 | 67% | 3.22 | 776 / 1155 |
breast | 62% | 65.29 | 284 / 459 | 66% | 2.51 | 740 / 1118 |
intestine | 96% | 157.72 | 924 / 966 | 21% | 0.55 | 111 / 527 |
stomach | 69% | 112.55 | 248 / 359 | 31% | 0.77 | 90 / 286 |
skin | 76% | 269.82 | 1375 / 1809 | 21% | 0.50 | 98 / 472 |
heart | 90% | 301.49 | 774 / 861 | 0% | 0 | 0 / 0 |
pancreas | 26% | 19.96 | 86 / 328 | 61% | 1.64 | 109 / 178 |
bladder | 62% | 69.86 | 13 / 21 | 22% | 0.62 | 111 / 504 |
peripheral blood | 56% | 102.83 | 520 / 929 | 0% | 0 | 0 / 0 |
spleen | 52% | 39.22 | 125 / 241 | 0% | 0 | 0 / 0 |
adipose | 45% | 40.77 | 541 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 42% | 1.86 | 19 / 45 |
blood vessel | 42% | 52.10 | 561 / 1335 | 0% | 0 | 0 / 0 |
adrenal gland | 5% | 3.57 | 12 / 258 | 23% | 0.60 | 54 / 230 |
eye | 0% | 0 | 0 / 0 | 16% | 0.28 | 13 / 80 |
liver | 0% | 0.26 | 1 / 226 | 7% | 0.17 | 28 / 406 |
muscle | 0% | 0.27 | 4 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0010975 | Biological process | regulation of neuron projection development |
GO_1990830 | Biological process | cellular response to leukemia inhibitory factor |
GO_0160111 | Cellular component | axonemal A tubule inner sheath |
GO_0005879 | Cellular component | axonemal microtubule |
GO_0036064 | Cellular component | ciliary basal body |
GO_0005874 | Cellular component | microtubule |
GO_0005509 | Molecular function | calcium ion binding |
GO_0005515 | Molecular function | protein binding |
Gene name | EFHC2 |
Protein name | EF-hand domain-containing family member C2 |
Synonyms | |
Description | FUNCTION: Microtubule inner protein (MIP) part of the dynein-decorated doublet microtubules (DMTs) in cilia axoneme, which is required for motile cilia beating. . |
Accessions | ENST00000420999.2 [Q5JST6-1] Q5JST6 |